PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+7.6%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$442M
AUM Growth
+$442M
(+12%)
Cap. Flow
+$48M
Cap. Flow
% of AUM
10.87%
Top 10 Holdings %
Top 10 Hldgs %
37.89%
Holding
92
New
17
Increased
38
Reduced
28
Closed
8
Top Buys
| 1 |
UnitedHealth
UNH
|
$19M |
| 2 |
CVS Health
CVS
|
$13.8M |
| 3 |
HCA Healthcare
HCA
|
$13M |
| 4 |
Danaher
DHR
|
$4.45M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$4.13M |
Top Sells
| 1 |
Humana
HUM
|
$7.39M |
| 2 |
DexCom
DXCM
|
$6.74M |
| 3 |
Arcus Biosciences
RCUS
|
$4.84M |
| 4 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$4.67M |
| 5 |
Insulet
PODD
|
$4.61M |
Sector Composition
| 1 | Healthcare | 98.05% |
| 2 | Industrials | 1.73% |
| 3 | Technology | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLRX
76
BioLineRX
BLRX
$16.2M
| $874K | 0.19% |
428,607
+17,547
| +4% | +$35.8K |
|
77
Quanterix
QTRX
$211M
| $848K | 0.19% |
+20,000
| New | +$848K |
|
|
ICAD
78
DELISTED
iCAD Inc
ICAD
| $744K | 0.16% |
103,302
-21,698
| -17% | -$156K |
|
79
Zymeworks
ZYME
$1.12B
| $682K | 0.15% |
41,625
+11,625
| +39% | +$190K |
|
|
ONCT
80
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $657K | 0.15% |
289,280
-36,104
| -11% | -$82K |
|
|
MTEM
81
DELISTED
Molecular Templates, Inc.
MTEM
| $579K | 0.13% |
147,728
+6,065
| +4% | +$23.8K |
|
82
Vera Therapeutics
VERA
$1.38B
| $576K | 0.13% |
21,555
-4,083
| -16% | -$109K |
|
83
Verastem
VSTM
$569M
| $376K | 0.08% |
183,332
+7,535
| +4% | +$15.5K |
|
84
Amgen
AMGN
$155B
| – | – |
-20,000
| Closed | -$4.25M |
|
85
BridgeBio Pharma
BBIO
$9.89B
| – | – |
-57,978
| Closed | -$2.72M |
|
86
Gyre Therapeutics
GYRE
$703M
| – | – |
-133,449
| Closed | -$548K |
|
|
87
Humana
HUM
$36.5B
| – | – |
-19,000
| Closed | -$7.39M |
|
88
Inotiv
NOTV
$58.1M
| – | – |
-97,500
| Closed | -$2.85M |
|
89
Vericel Corp
VCEL
$1.83B
| – | – |
-20,340
| Closed | -$993K |
|
90
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|
|
CALA
91
DELISTED
Calithera Biosciences, Inc
CALA
| – | – |
-100,628
| Closed | -$219K |
|
|
DRNA
92
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-209,686
| Closed | -$4.23M |
|